156 related articles for article (PubMed ID: 28146433)
1. High-dose radiotherapy is associated with better local control of bone metastasis from hepatocellular carcinoma.
Jung IH; Yoon SM; Kwak J; Park JH; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Oncotarget; 2017 Feb; 8(9):15182-15192. PubMed ID: 28146433
[TBL] [Abstract][Full Text] [Related]
2. Radiation treatment outcomes for unresectable hepatocellular carcinoma.
Skinner HD; Sharp HJ; Kaseb AO; Javle MM; Vauthey JN; Abdalla EK; Delclos ME; Das P; Crane CH; Krishnan S
Acta Oncol; 2011 Nov; 50(8):1191-8. PubMed ID: 21793641
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation using helical tomotherapy improves local control in spine metastases from primary hepatic malignancies.
Choi Y; Kim J; Lee I; Seong J
Liver Int; 2014 Mar; 34(3):462-8. PubMed ID: 23859251
[TBL] [Abstract][Full Text] [Related]
4. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
Seong J; Koom WS; Park HC
Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients.
Kaizu T; Karasawa K; Tanaka Y; Matuda T; Kurosaki H; Tanaka S; Kumazaki T
Am J Gastroenterol; 1998 Nov; 93(11):2167-71. PubMed ID: 9820391
[TBL] [Abstract][Full Text] [Related]
7. High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma.
Kim T; Cha HJ; Kim JW; Seong J; Lee IJ
Oncotarget; 2016 Aug; 7(33):53921-53929. PubMed ID: 27259272
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy for lymph node metastases from hepatocellular carcinoma.
Toya R; Murakami R; Yasunaga T; Baba Y; Nishimura R; Morishita S; Nishi J; Beppu T; Baba H; Yamashita Y; Oya N
Hepatogastroenterology; 2009; 56(90):476-80. PubMed ID: 19579624
[TBL] [Abstract][Full Text] [Related]
9. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma.
Kim TH; Park S; Rim CH; Choi C; Seong J
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2693-2700. PubMed ID: 33582874
[TBL] [Abstract][Full Text] [Related]
10. [Radiation therapy for bone metastasis from hepatocellular carcinoma].
Koom WS; Seong JS; Lee MJ; Park HC; Han KH; Chon JY; Moon YM; Suh CO
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):304-11. PubMed ID: 12499788
[TBL] [Abstract][Full Text] [Related]
11. Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy.
Habermehl D; Haase K; Rieken S; Debus J; Combs SE
Tumori; 2011; 97(5):609-13. PubMed ID: 22158492
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationship in local radiotherapy for hepatocellular carcinoma.
Park HC; Seong J; Han KH; Chon CY; Moon YM; Suh CO
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):150-5. PubMed ID: 12182985
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma.
Choi SH; Chang JS; Jeong YH; Lee Y; Yun M; Seong J
Liver Int; 2014 Aug; 34(7):1118-25. PubMed ID: 24528941
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy for bone metastases from hepatocellular carcinoma and pancreas cancer].
Harada H; Nishimura T; Kamata M; Asakura H; Zenda S; Takahashi M; Katagiri H; Takagi T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1061-4. PubMed ID: 16912522
[TBL] [Abstract][Full Text] [Related]
15. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
16. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14-17).
Kim M; Kay CS; Jang WI; Kim MS; Lee DS; Jang HS
Medicine (Baltimore); 2017 Jun; 96(24):e7202. PubMed ID: 28614265
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for adrenal gland metastases from hepatocellular carcinoma.
Yuan BY; Hu Y; Zhang L; Chen YH; Dong YY; Zeng ZC
Clin Transl Oncol; 2017 Sep; 19(9):1154-1160. PubMed ID: 28357632
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
Sandroussi C; Dawson LA; Lee M; Guindi M; Fischer S; Ghanekar A; Cattral MS; McGilvray ID; Levy GA; Renner E; Greig PD; Grant DR
Transpl Int; 2010 Mar; 23(3):299-306. PubMed ID: 19843294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
